Company Logo

nivolumab

Agricultural Biotechnology

Updated on Sep 13, 2020

View more like this | Visit SHIRLEY, NY | Contact Bella Smith
Image for nivolumab with ID of: 4428358
Recombinant human monoclonal antibody expressed in CHO binding to human PDCD1. Nivolumab is a fully human IgG4 monoclonal antibody for the treatment of cancer. Nivolumab acts as an immunomodulator by blocking ligand activation of the programmed cell death 1 (PD-1) receptor on activated T cells.
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.